This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Buspirone
The cleanest pharmaceutical anxiolytic — partial 5-HT1A agonist, non-controlled, non-sedating, non-addictive, cognitively neutral.
Aliases (6)
Overview
What is Buspirone?
Buspirone (brand name Buspar) is an FDA-approved azapirone-class anxiolytic used for generalized anxiety disorder. It is non-sedating, non-addictive, and structurally and mechanistically distinct from benzodiazepines — no GABA activity.
Key Benefits
Effective for chronic generalized anxiety with no sedation, no dependence, no respiratory depression, and no abuse potential. Useful in patients where benzodiazepines are contraindicated; takes 2-4 weeks to reach full effect.
Mechanism of Action
Partial agonist at presynaptic 5-HT1A autoreceptors (down-regulating serotonin firing acutely, then post-synaptic upregulation chronically) and weak D2 antagonist. No GABAergic activity, hence no sedation or dependence.
Pharmacokinetics
Research Indications
1-PP (1-pyrimidinylpiperazine)
a major metabolite (about 6× higher plasma levels than parent compound) that is an alpha-2 adrenergic antagonist. Contributes some of the…
Peptide Interactions
Documented augmentation strategy; covers serotonergic anxiety from two angles
For performance-anxiety overlay (somatic symptoms covered by propranolol; cognitive worry covered by buspirone) — well-tolerated combination
Mild additive calming without overlap; safe
Adaptogen support layer; safe combination
Hypertensive crisis and serotonin syndrome risk
4-13× increased buspirone exposure; reduce dose or avoid
Reduced exposure; may need higher dose
What to Expect
- Acute(single dose): Mostly nothing felt. Some users report mild dizziness, light-headedness, or transient nausea 30-60 min post-dose.
- Chronic(2-4 weeks): Anxiety floor lifts gradually. Less reactive to triggers. Sleep may improve indirectly. NOT a "calmness on demand" effect — that's the benzo pro…
Side Effects & Safety
- Common (>10%): Dizziness, headache, nausea (especially first 1-2 weeks)
- Less common (1-10%): Light-headedness, restlessness, diarrhea, paresthesias
- Rare-serious (<1%): Serotonin syndrome (in combination with MAOIs, high-dose SSRIs); EPS/movement disorders (very rare, related to weak D2 effect); allergic reactions
- Specific watch periods: First 2 weeks for tolerability; 4-week mark to assess clinical response
References
Goldberg 1979 — Buspirone vs diazepam in anxiety (early efficacy trial)
Rickels et al. 1982 — Buspirone vs diazepam in chronic anxiety (Arch Gen Psychiatry)
Chessick et al. 2006 — Cochrane meta-analysis of azapirones for GAD
Mahmood & Sahajwalla 1999 — Clinical pharmacokinetics and pharmacodynamics of buspirone (Clin Pharmacokinet review)
Howland 2015 — Buspirone: back to the future (J Psychosoc Nurs Ment Health Serv review)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.